256 related articles for article (PubMed ID: 11004045)
1. A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
Kross RA; Ferri E; Leung D; Pratila M; Broad C; Veronesi M; Melendez JA
Anesth Analg; 2000 Oct; 91(4):904-9. PubMed ID: 11004045
[TBL] [Abstract][Full Text] [Related]
2. Nicardipine is superior to esmolol for the management of postcraniotomy emergence hypertension: a randomized open-label study.
Bebawy JF; Houston CC; Kosky JL; Badri AM; Hemmer LB; Moreland NC; Carabini LM; Koht A; Gupta DK
Anesth Analg; 2015 Jan; 120(1):186-192. PubMed ID: 25296247
[TBL] [Abstract][Full Text] [Related]
3. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
El-Ghoroury H; Sudekum DM; Hecht JP
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105959. PubMed ID: 34217067
[TBL] [Abstract][Full Text] [Related]
4. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Malesker MA; Hilleman DE
J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
[TBL] [Abstract][Full Text] [Related]
5. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
Hecht JP; Richards PG
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
[TBL] [Abstract][Full Text] [Related]
6. Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study.
Ryu JH; Apfel CC; Whelan R; Jeon YT; Hwang JW; Do SH; Ro YJ; Kim CS
Clin Ther; 2012 Mar; 34(3):593-604. PubMed ID: 22364823
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
8. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.
Peacock WF; Varon J; Baumann BM; Borczuk P; Cannon CM; Chandra A; Cline DM; Diercks D; Hiestand B; Hsu A; Jois-Bilowich P; Kaminski B; Levy P; Nowak RM; Schrock JW
Crit Care; 2011; 15(3):R157. PubMed ID: 21707983
[TBL] [Abstract][Full Text] [Related]
9. The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine.
Nooij LS; Visser S; Meuleman T; Vos P; Roelofs R; de Groot CJ
Curr Pharm Biotechnol; 2014; 15(1):64-9. PubMed ID: 24720593
[TBL] [Abstract][Full Text] [Related]
10. The use of nicardipine for electroconvulsive therapy: a dose-ranging study.
Zhang Y; White PF; Thornton L; Perdue L; Downing M
Anesth Analg; 2005 Feb; 100(2):378-381. PubMed ID: 15673861
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.
Avramov MN; Stool LA; White PF; Husain MM
J Clin Anesth; 1998 Aug; 10(5):394-400. PubMed ID: 9702620
[TBL] [Abstract][Full Text] [Related]
12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
13. Labetalol Use Is Associated With Increased In-Hospital Infection Compared With Nicardipine Use in Intracerebral Hemorrhage.
Starr JB; Tirschwell DL; Becker KJ
Stroke; 2017 Oct; 48(10):2693-2698. PubMed ID: 28904237
[TBL] [Abstract][Full Text] [Related]
14. The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation.
Atlee JL; Dhamee MS; Olund TL; George V
Anesth Analg; 2000 Feb; 90(2):280-5. PubMed ID: 10648307
[TBL] [Abstract][Full Text] [Related]
15. The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine?
Varon J; Soto-Ruiz KM; Baumann BM; Borczuk P; Cannon CM; Chandra A; Cline DM; Diercks DB; Hiestand B; Hsu A; Jois-Bilowich P; Kaminski B; Levy P; Nowak RM; Schrock JW; Peacock WF
Postgrad Med; 2014 Jul; 126(4):124-30. PubMed ID: 25141250
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage.
Ortega-Gutierrez S; Thomas J; Reccius A; Agarwal S; Lantigua H; Li M; Carpenter AM; Mayer SA; Schmidt JM; Lee K; Claassen J; Badjatia N; Lesch C
Neurocrit Care; 2013 Feb; 18(1):13-9. PubMed ID: 23055089
[TBL] [Abstract][Full Text] [Related]
18. Nicardipine versus Labetalol for Hypertension during Acute Stroke: A Systematic Review and Meta-Analysis.
Hao F; Yin S; Tang L; Zhang X; Zhang S
Neurol India; 2022; 70(5):1793-1799. PubMed ID: 36352567
[TBL] [Abstract][Full Text] [Related]
19. Intravenous antihypertensive agents for patients unable to take oral medications.
Zigmont EA; Connelly JF
Am J Health Syst Pharm; 1995 Jul; 52(14):1514-6, 1518. PubMed ID: 7552893
[TBL] [Abstract][Full Text] [Related]
20. [A comparative analysis of the antihypertensive activity of calcium antagonists and adrenoblockers in long-term treatment].
Svishchenko EP; Kupchinskaia EG; Zanozdra NS; Bezrodnaia LV; Radchenko VV
Klin Med (Mosk); 1992; 70(11-12):34-7. PubMed ID: 1363481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
